Pneumococcal disease and the impact of pneumococcal conjugate vaccines

Keyphrases

• Pneumococcal Disease 100%
• Pneumococcal Conjugate Vaccine 100%
• Invasive Pneumococcal Disease 100%
• Community-acquired Pneumonia 57%
• Herd Effect 57%
• PCV7 57%
• Vaccine Serotypes 57%
• Disease Incidence 28%
• PCV10 28%
• 13-valent Pneumococcal Conjugate Vaccine (PCV13) 28%
• Pneumonia Patients 28%
• Nasopharyngeal Microbiota 28%
• Dutch 14%
• Risk Factors 14%
• Age Groups 14%
• Etiology 14%
• AIDS/HIV 14%
• Fatality 14%
• National Immunization Program 14%
• Unvaccinated 14%
• Streptococcus Pneumoniae 14%
• S. Pneumoniae 14%
• All Ages 14%
• Immunogenic 14%
• Clinical Syndromes 14%
• Chronic Lung Disease 14%
• Long-term Mortality 14%
• Group 13 14%
• Epidemiological Factors 14%
• Chronic Cardiovascular Diseases 14%
• Empyema 14%
• Hospitalized Adults 14%
• Societal Impacts 14%
• Disease Case 14%
• 5-year-old 14%
• Capsular Switch 14%
• Extent of Disease 14%
• Vaccine Implementation 14%
• Microbiological Etiology 14%

Medicine and Dentistry

• Disease 100%
• Pneumococcus Vaccine 100%
• Pneumococcal Infection 77%
• Serotype 66%
• Community-Acquired Pneumonia 44%
• Herd 44%
• Pathogen 33%
• Morbidity 22%
• Case Fatality Rate 11%
• Cardiovascular Disease 11%
• Clinical Syndrome 11%
• Chronic Lung Disease 11%
• Pneumococcus 11%
• HIV/AIDS 11%
• Empyema 11%
• Pneumococcal Pneumonia 11%
• Microbiome 11%
• Streptococcus Pneumonia 11%

Immunology and Microbiology

• Pneumococcal Vaccine 100%
• Serotype 66%
• Herd 44%
• Infectious Agent 33%
• Morbidity 22%
• Pneumococcus 11%
• Microbiome 11%
• HIV/AIDS 11%
• Case Fatality Rate 11%
• Empyema 11%
• Streptococcus Pneumonia 11%